http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106074507-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4f261d1abe09c80caff60d34649a4c19
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-045
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-122
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-045
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-407
filingDate 2016-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_926a395d03d1a8edf1eabc4da54535da
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6f3230e5c56d6a7ab5057f649bf90c17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fb4006bebc9c9c50e134a72ef7a267bc
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af11d6e3df0d91f315def8157ef9b567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_92b6c52c03fb45265ac8ff425111ef14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f0f09e0b57359abe0621d3a00535edfe
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbf986d870807232c29a28ebbfc25146
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9224ad59e76daf720036fe1b42d7a1d3
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0726787d5bdbdc4d3dc6888718043314
publicationDate 2016-11-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-106074507-A
titleOfInvention Pharmaceutical composition that prevention of arterial is atherosis and application thereof
abstract The invention belongs to the atherosis pharmaceutical composition of a kind of prevention of arterial and application thereof；It is formulated that this pharmaceutical composition comprises following raw materials according: hinesol, dendrobine, Rubiadin；Having can effectively prevention of arterial be atherosis and effect is obvious, the advantage that Quality Control is stably suitable to patient's long-term taking.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3943085-A3
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107050005-A
priorityDate 2016-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506484
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID102615
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID433322137
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420663450
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419582564
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53232
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425964789
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415967108
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID154496457
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10059437
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426154599
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID124062
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID442523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3080635

Total number of triples: 41.